Theralase should take note of this. Saudi Arabia,s sovereign wealth fund on Sunday launched a commercial scale contract development and manufacturing organization , Lifera , to help boost the local biopharmaceutical industry.
It seeks to bolster Saudi Arabia,s position as a global pharmaceutical manufacturing destination by investing to enable a leading health sector in Saudi Arabia to support the development of , and access to , asvanced medicines and treatments.
The company will create partnerships with others to attract targeted investments to boost local capacity and drive the development of domestic manufacturing in this sector.
Lifera intends to partner with others to localize manufacturing ,attract investment and enable the private sector to scale up ,ensuring easier access for patients ,while securing the supply of life saving medicines that can meet local, regional and global demand. Also the pharmaceutical investment company aims to focus on manufacturing life - saving and essential pharmaceutical products ,including insulins , vaccines , plasma therapeutics ,antibodies ,cell and gene therapies ,and inovative small molecules , said an official.
All in all , it seeks to bolster Saudi Arabia,s position as a global pharmaceutical manufacturing destination by driving formulation development ,medicine development, manufacturing and investing services for sterile pharmaceutical products.